Racial and Ethnic Disparities and Health Inequities in Oncology Care


Edith Peterson Mitchell, MD, MACP, FCPP, FRCP
Clinical Professor of Medicine and Medical Oncology Department of Medical Oncology
Director, Center to Eliminate Cancer Disparities Associate Director, Diversity Affairs
Sidney Kimmel Cancer Center at Jefferson Philadelphia, PA 116th President of the National Medical Ass
Edith Peterson Mitchell, MD, MACP, FCPP, FRCP

Edith Peterson Mitchell, MD, MACP, FCPP, FRCP, is board certified in Internal Medicine and Medical Oncology and is Clinical Professor of Medicine and Medical Oncology at Sidney Kimmel Medical College at Thomas Jefferson University and Associate Director for Diversity Programs and Director of the Center to Eliminate Cancer Disparities for Sidney Kimmel Cancer Center at Jefferson.

Dr. Mitchell has spent her medical career helping individuals in medically underserved areas and has demonstrated the importance of community service and outreach, especially to underserved populations. Her research in breast, colorectal, and pancreatic cancers and other GI malignancies involves new drug evaluation and chemotherapy, development of new therapeutic regimens, chemoradiation strategies for combined-modality therapy, patient selection criteria, and supportive care for patients with gastrointestinal cancer.

Dr. Mitchell served as the 116th President of the National Medical Association, and is a member of the American Medical Association, National Medical Association, Aerospace Medical Association, Association of Military Surgeons, Medical Society of Eastern Pennsylvania, ECOG/ACRIN Cancer Research Group, and Radiation Therapy Oncology Group. Because of her experience in the cancer research community, Dr. Mitchell served as a member of the National Cancer Institute Blue Ribbon Panel convened to advise the National Cancer Advisory Board on then Vice President Biden’s National Cancer Moonshot Initiative. In 2019, Dr. Mitchell began service as a member of the President’s Cancer Panel. In 2020, she became a Fellow of the Royal College of Physicians.

In addition to her medical achievements, Dr. Mitchell is a retired United States Air Force Brigadier General.

Ajay K. Nooka, MD, MPH, FACP
Associate Professor, Atlanta, GA
Associate Professor, Department of Hematology and Medical Oncology
Medical Director, Winship Data and Technology Applications Shared Resource
Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
Ajay K. Nooka, MD, MPH, FACP
Associate Professor, Atlanta, GA

Dr. Ajay Nooka is an Associate Professor in the Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University in Atlanta, Georgia. He earned his medical degree from Andhra Medical College in Visakhapatnam, India, before relocating to the United States. He received a Master’s in Public Health from the University of Texas School of Public Health in Houston, Texas, and then completed his internship and residency at the Northeastern Ohio University College of Medicine in Athens, Ohio. He pursued a fellowship in Hematology and Oncology at Emory University School of Medicine, where he also served as Chief Fellow before he joined the faculty.

Board certified in Hematology and Medical Oncology, Dr. Nooka primarily focuses on multiple myeloma treatment and research. He is the Scientific Director of Data and Technology Applications at Winship Cancer Institute, Director of the Myeloma Program, and Chair of the Myeloma Working Group at the Department of Hematology and Oncology at Emory University. He is involved in numerous professional organizations, including the International Myeloma Working Group of the International Myeloma Society, American Society of Clinical Oncology, American Society of Hematology, and American Society for Transplantation and Cellular Therapies. Dr. Nooka?s interests as a clinical investigator focus on multiple myeloma and bone marrow transplant. His research interests include integrating genomic and clinical data on a uniform platform to risk-stratify myeloma as well as evaluate newer myeloma therapeutic strategies aimed at prolonging survival of patients with myeloma.

In addition to leading several investigator-initiated and industry-sponsored clinical trials, he is the recipient of several awards and grants and has published more than 300 articles and abstracts in high-quality, peer-reviewed journals including New England Journal of Medicine, Journal of Clinical Oncology, Blood, Leukemia, Lancet Oncology, and Cancer. He serves on the editorial board of the American Journal of Clinical Oncology and as an invited or ad hoc reviewer for several prestigious journals including Journal of Clinical Oncology, Lancet Oncology, Leukemia, Cancer, Blood Advances, Blood Cancer Journal, American Journal of Hematology, British Journal of Hematology, Bone Marrow Transplantation, and Biology of Blood and Marrow Transplantation.

Yaw A. Nyame, MD, MS, MBA
Assistant Professor, Seattle, WA
Assistant Professor, Department of Urology, University of Washington
Associate Director, Center for Urologic Research and Education
Program Lead for Black/African American Populations, Office of Community Outreach and Engagement, Fred Hutchinson Cancer Center
Seattle, WA
Yaw A. Nyame, MD, MS, MBA
Assistant Professor, Seattle, WA

Yaw A. Nyame, MD, MS, MBA, is a urologic oncologist with a research interest in health disparities in urologic cancers, with a focus on using patient-centered approaches to build translational health services, molecular and clinical solutions to health inequities in prostate cancer, and other urologic malignancies.

He attended medical school at the Feinberg School of Medicine at Northwestern University and business school at the Kellogg School of Management at Northwestern University in Illinois, graduating in 2012. Prior to medical school, he completed a master’s in Health Services and Administration at the School of Public Health at George Washington University in Washington, D.C. He completed his urology residency training at the Glickman Urological and Kidney Institute at the Cleveland Clinic and a Society of Urologic Oncology (SUO) fellowship at the University of Washington, where he joined the faculty upon the completion of his training.

Ana I. Velázquez Mañana, MD, MSc
Assistant Professor, Division of Hematology Oncology, Zuckerberg San Francisco General Hospital
Assistant Director of Diversity, Equity, Inclusion and Accessibility, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Ana I. Velázquez Mañana, MD, MSc

Dr. Ana Velázquez Mañana is a thoracic oncologist and Assistant Professor of Medicine in the University of California, San Francisco (UCSF) Division of Hematology/Oncology at Zuckerberg San Francisco General Hospital in California. As a Latina, she advocates for workforce diversity and gender equity and has been named the Assistant Director of Diversity, Equity, Inclusion, and Accessibility for Training of the Helen Diller Family Comprehensive Cancer Center at UCSF. Dr. Velázquez completed her MD at the University of Puerto Rico School of Medicine, a Master of Biomedical Science at Mayo Clinic Graduate School of Biomedical Sciences (formerly known as Mayo Graduate School), and her Internal Medicine residency at Mount Sinai Beth Israel, where she was a Chief Resident. She joined UCSF in 2018, where she completed her clinical fellowship in Medical Oncology and postdoctoral research fellowship in the National Clinician Scholars Program.

Dr. Velázquez is a member of the prestigious John A. Watson Faculty Scholars Class of 2022 at UCSF and has been awarded a Conquer Cancer Foundation Young Investigator Award. She aims to support and improve the outcomes of patients with lung cancer from vulnerable backgrounds using health services and disparities research.

Statement of Need

There are many factors that lead to health care disparities in oncology care and outcomes for racial and ethnic populations, including root causes such as structural racism, social determinants of health (SDoH), and geographic location. As with other areas of health care, individuals with low income, low health literacy, transportation barriers, or lack of health insurance or paid leave are far less likely to be screened for cancer or managed according to guideline-directed treatment. Thus, underserved patient populations are more likely to be diagnosed with late-stage cancers, leading to worse outcomes and higher mortality. Furthermore, individuals of racial and ethnic groups seeking or receiving oncology care are disproportionately impacted by unconscious and conscious bias, which exacerbates poorer outcomes.

While oncology treatments continue to advance in the era of modern medicine, the healthcare system remains plagued by longstanding health inequities. It is imperative that all members of the health care team recognize their important roles in providing education, services, and equitable care for all patients. In this enduring CME Outfitters webcast, expert faculty will discuss the impact of unconscious and systemic biases, SDoH, and regional, racial, and ethnic disparities and provide tools and resources to improve oncology care for all patients.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

  • Analyze ethnic and regional disparities resulting in health inequities in oncology care.
  • Improve recognition of multiple myeloma, melanoma, prostate, and lung cancers.
  • Analyze the influence of SDoH in cancer care in order to improve equity and accessibility to cancer treatments and outcomes.

Financial Support

Supported by an educational grant provided by the Johnson & Johnson Institute and the Johnson & Johnson Family of Companies.

Target Audience

Physicians, physician associates (PAs), nurse practitioners (NPs), nurses/nurse navigators, pharmacists, psychologists, dietitians, social workers, and other professionals specializing in diagnosing or treating patients with cancer

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional (IPCE) 1.5

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) Credit for learning and change.

Physicians (ACCME) 1.5

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.5

This activity is designated for 1.5 contact hours.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Pharmacists (ACPE) 1.5

This application-based activity is approved for 1.5 contact hours (0.15 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-22-102-H01-P

Psychologists (APA) 1.5

Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs.

Dentists (ADA CERP) 1.5

ADA CERP: CME Outfitters, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP. CME Outfitters, LLC designates this activity for 1.5 continuing education credits. Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

PAs (AAPA) 1.5

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

Dietetics (CDR)

Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU). RDs and DTRs are to select activity type 102 in their Activity Log. Performance indicator selection is at the learner’s discretion.

Social Work (ACE) 1.5

As a Jointly Accredited Organization, CME Outfitters, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. CME Outfitters, LLC maintains responsibility for this course. Social workers completing this course receive 1.5 intermediate continuing education credits.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Mitchell reports the following financial relationships:

Advisory Board: Corvus Pharmaceuticals, Inc.

Consultant: Amgen Inc.; Astellas Pharma Inc.; Bristol Myers Squibb; Genentech, Inc.; and SEMA4 OpCo, Inc.

Dr. Nooka reports the following financial relationships:

Advisory Board Adaptive Biotechnologies; Amgen Inc.; BeyondSpring Inc.; Bristol Myers Squibb Company; GSK; Janssen Pharmaceuticals, Inc.; Karyopharm; Oncopeptides, Inc.; Pfizer Inc.; Sanofi; Secura Bio, Inc.; and Takeda Pharmaceuticals U.S.A., Inc..

Grant/Research Support (to Emory University): Amgen Inc.; Arch Oncology; Bristol Myers Squibb Company; Genentech, Inc.; GSK; Janssen Pharmaceuticals, Inc.; Karyopharm; Kite; Merck & Co., Inc.; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Grant/Research Support (for investigator-initiated studies): Amgen Inc.; GSK; Janssen Pharmaceuticals, Inc.; Merck; and Takeda Pharmaceuticals U.S.A., Inc.

Dr. Nyame reports the following financial relationships:

Research Consultant: Ortho Clinical Diagnostics

Dr. Velázquez Mañana reports the following financial relationships:

Stock Shareholder (directly purchased): Corbus Pharmaceuticals Holdings, Inc.

Other Financial or Material Support:LEAD Conference advisory committee member organized by BioAscend; Stipend from MDOutlook and Curio Science; and Travel Support from DAVA Oncology

The following peer reviewer and CME Outfitters staff have no financial relationships:

  • Jeffrey Helfand, DO (peer reviewer)
  • Meghann Taft-Lockard (planning committee)
  • Kashemi Rorie, PhD (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at (877) CME-PROS or (877) 263-7767.



Racial and Ethnic Disparities and Health Inequities in Oncology Care
Event Date: 08/26/2022